Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Review ArticleExperimental StudiesR

Phenothiazines, Bacterial Efflux Pumps and Targeting the Macrophage for Enhanced Killing of Intracellular XDRTB

LEONARD AMARAL, ANA MARTINS, JOSEPH MOLNAR, JETTE E KRISTIANSEN, MARTA MARTINS, MIGUEL VIVEIROS, LILIANA RODRIGUES, GABRIELLA SPENGLER, ISABEL COUTO, JORGE RAMOS, SUJATA DASTIDAR, SÉAMUS FANNING, MATT MCCUSKER and JEAN-MARIE PAGES
In Vivo July 2010, 24 (4) 409-424;
LEONARD AMARAL
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: lamaral{at}ihmt.unl.pt
ANA MARTINS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JOSEPH MOLNAR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JETTE E KRISTIANSEN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARTA MARTINS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MIGUEL VIVEIROS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LILIANA RODRIGUES
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GABRIELLA SPENGLER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ISABEL COUTO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JORGE RAMOS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SUJATA DASTIDAR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SÉAMUS FANNING
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MATT MCCUSKER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JEAN-MARIE PAGES
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Phenothiazines have their primary effects on the plasma membrane of prokaryotes and eukaryotes. Among the components of the prokaryotic plasma membrane affected are efflux pumps, their energy sources, energy providing enzymes such as ATPases, and genes that regulate and code for permeability aspects of the bacterium. The responses of multi-drug (MDR) and extensively drug resistant (XDR) Mycobacterium tuberculosis to the neuroleptic phenothiazine thioridazine are reviewed. The information collated suggests that this phenothiazine has the potential to cure XDR and MDR tuberculosis infections, a potential that has been recently demonstrated by its ability to cure 10 patients who presented with XDR TB infections. The mechanism by which this phenothiazine produces the desired effects within the infected macrophage is also discussed.

  • Phenothiazines
  • thioridazine
  • pulmonary tuberculosis
  • MDR TB
  • XDR TB
  • human macrophage
  • enhanced killing activity by macrophage
  • efflux pumps
  • therapy with thioridazine
  • review

Footnotes

  • Copyright © 2010 The Author(s). Published by the International Institute of Anticancer Research.
View Full Text
PreviousNext
Back to top

In this issue

In Vivo
Vol. 24, Issue 4
July-August 2010
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Phenothiazines, Bacterial Efflux Pumps and Targeting the Macrophage for Enhanced Killing of Intracellular XDRTB
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 5 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Phenothiazines, Bacterial Efflux Pumps and Targeting the Macrophage for Enhanced Killing of Intracellular XDRTB
LEONARD AMARAL, ANA MARTINS, JOSEPH MOLNAR, JETTE E KRISTIANSEN, MARTA MARTINS, MIGUEL VIVEIROS, LILIANA RODRIGUES, GABRIELLA SPENGLER, ISABEL COUTO, JORGE RAMOS, SUJATA DASTIDAR, SÉAMUS FANNING, MATT MCCUSKER, JEAN-MARIE PAGES
In Vivo Jul 2010, 24 (4) 409-424;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Phenothiazines, Bacterial Efflux Pumps and Targeting the Macrophage for Enhanced Killing of Intracellular XDRTB
LEONARD AMARAL, ANA MARTINS, JOSEPH MOLNAR, JETTE E KRISTIANSEN, MARTA MARTINS, MIGUEL VIVEIROS, LILIANA RODRIGUES, GABRIELLA SPENGLER, ISABEL COUTO, JORGE RAMOS, SUJATA DASTIDAR, SÉAMUS FANNING, MATT MCCUSKER, JEAN-MARIE PAGES
In Vivo Jul 2010, 24 (4) 409-424;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • The Threat of Multidrug-resistant Infections and the Chemotherapeutic Potential of Phenothiazines
    • Targets of Phenothiazines
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Unraveling fungal endolysosomal network as a potential target for effective disease control
  • New Multidrug Efflux Inhibitors for Gram-Negative Bacteria
  • Mechanisms by which Thioridazine in Combination with Antibiotics Cures Extensively Drug-resistant Infections of Pulmonary Tuberculosis
  • Inhibitors of Bacterial Efflux Pumps that also Inhibit Efflux Pumps of Cancer Cells
  • Google Scholar

More in this TOC Section

  • The Role of ACE I/D Polymorphism in Glioblastoma Pathogenesis: A Study on the Turkish Population
  • Freezing Nitrogen–Ethanol Composite Effectively Eradicates Staphylococcus aureus Biofilm on Prosthetic Surfaces
  • Obesity and Pro-Inflammatory Cytokines: Gene Expression Patterns Within Cervical Cancer Progression
Show more Experimental Studies
In Vivo

© 2026 In Vivo

Powered by HighWire